Hunterian Medicine LLC — Form D/A

Hunterian Medicine LLC of BALTIMORE, MD, a company, filed a Form D amendment with the SEC on 2018-09-18. $2.7M was reported sold. Industry: Biotechnology.

Offering

Filed: 2018-09-18
Form: D/A
Accession: 0001685325-18-000001
Industry: Biotechnology
Exemptions: 06b
Amount sold: $2.7M
Minimum investment: $50K
Investors: 15
Date of first sale: 2016-09-11
Security types: debt
Revenue range: No Revenues
SEC file number: 021-271156

Issuer

Name: Hunterian Medicine LLC
CIK: 0001685325
Entity type: Limited Liability Company
Jurisdiction: DELAWARE
Incorporated: 2016
Address: 2401 WEST BELVEDERE AVE., BALTIMORE, MD, 21215
Phone: 888-486-8633

Officers, directors & promoters (5)

Name	Role	Location
Vinod Jaskula-Ranga	Director	BALTIMORE, MD
Vinod Jaskula-Ranga	Executive Officer	BALTIMORE, MD
James Akiva Silverglad	Promoter	Astoria, NY
Vinod Ranganathan	Director	Baltimore, MD
Vinod Ranganathan	Executive Officer	Baltimore, MD

Other filings by this issuer (8)

Filed	Form	Offering	Sold
2024-09-25	D/A	—	$4.6M
2023-09-21	D/A	—	$4.6M
2022-09-23	D/A	—	$4.1M
2021-09-17	D/A	—	$3.9M
2020-09-18	D/A	—	$3.5M
2019-09-18	D/A	—	$3.1M
2017-09-20	D/A	—	$2.1M
2016-09-23	D	$2.0M	$230K

More